W. Kast was born in Haarlem, The Netherlands, in 1958. He received the M.S. degree in medical biology and the Ph.D. degree in medicine (both summa cum laude) from the University of Amsterdam, Amsterdam, The Netherlands, in 1983 and 1987, respectively. Since 2003, he serves as a Walter A. Richter Cancer Research Chair and as a Professor of molecular microbiology and immunology, obstetrics and gynecology, and urology at the Norris Comprehensive Cancer Center of the University of Southern California in Los Angeles, Calif, USA. Since 2009, he also holds a position as an Adjunct Professor of cancer research at the University of Hawaii in Honolulu, Hawaii, USA. Before the current positions, he had faculty positions at Loyola University Medical Center, Chicago, Ill, USA, Leiden University Medical Center, Leiden, The Netherlands, and The Netherlands Cancer Institute, where he also did his postdoctoral training. He served as a Visiting Senior Scientist at the biotech company Cytel in San Diego, Calif, USA, and as a Visiting Professor at the Pittsburgh Cancer Institute in 1992 and 1994, respectively. His research involves the design of therapeutic cancer vaccines directed against human papilloma virus (HPV) and prostate cancer. Several of his therapeutic HPV vaccines have been tried out in clinical trials. He also studies the interaction of HPV with the human immune system to find out how HPV escapes immune detection and how to reverse that. He has published over 225 articles and 50 book chapters and has 14 patents. He is the recipient of the Antoni van Leeuwenhoek Award, the Royal Netherlands Academy of Arts and Sciences Award, and the IRPC Award. He works as an Associate Editor for the Journal of Translational Medicine, International Reviews of Immunology, HPV Today, and Clinical and Developmental Immunology. He currently serves on the advisory boards of 5 biotechnology companies.
Biography Updated on 26 January 2011